Bandaríkin - enska - NLM (National Library of Medicine)

sun pharmaceutical industries limited - carisoprodol (unii: 21925k482h) (carisoprodol - unii:21925k482h) - carisoprodol 350 mg

Bandaríkin - enska - NLM (National Library of Medicine)

delaval - glycolic acid (unii: 0wt12sx38s) (glycolic acid - unii:0wt12sx38s) - glycolic acid 30.4 g in 1 l - sanitizing post dip barrier with 5% glycerin aids in reducing the spread of mastitis-causing organisms desinfectante post ordeno con 5% de glicerina ayuda a reducir la transmision de microorganismos que causan mastitis general instructions - delaval oceanblu® pre-post is a pre and post milking sanitizing teat dip that aids in reducing the spread of mastitis-causing organisms. - use delaval ocean blu® pre-post teat sanitizer at full strength.  do not dilute. - consult veterinarian before starting or continuing to use teat dip if cow's teats are sore or chapped. - thoroughly clean and sanitize teat dip cup before each milking. - use fresh teat dip for each milking.  dip solution should be changed if it becomes visibly dirty or if sediment is introduced.  do not pour used teat dip back into original container. - discard any teat sanitizing solution that becomes dirty or contaminated for any reason. - good dairy practices suggest the thorough cleaning and sanitizing of teats before milking to avoid contamina

Bandaríkin - enska - NLM (National Library of Medicine)

delaval - lactic acid (unii: 33x04xa5at) (lactic acid - unii:33x04xa5at) - lactic acid 146.7 g in 1 l

Bandaríkin - enska - NLM (National Library of Medicine)

delaval - iodine (unii: 9679tc07x4) (iodine - unii:9679tc07x4) - iodine 10.5 g in 1 l - general instructions - use at full strength.  (do not dilute.) - do not use della one plus for cleaning or sanitizing equipment. - dip solution should be changed if it becomes visibly dirty, if sediment is present, or if the amber color noticeably fades. - do not pour used teat dip back into the original container. - thoroughly clean and sanitize teat dip foaming cup before each milking.  use fresh teat dip for each milking. - if product is frozen, thaw completely and shake well before use. pre-dipping - after teats have been properly cleaned, dip each teat with an approved delaval teat dip. - allow product to stay on tests 15 to 30 seconds, then wipe dry with a clean single-service cloth or paper towel. - examine each quarter with strip cup before applying milking machine. - immediately after removing milking unit, dip teats with della one plus teat dip.  do not wipe. - while cow is being dried off, dip teats in della one plus for several days following milking. - if outside temperature is below freezing,

Bandaríkin - enska - NLM (National Library of Medicine)

froggy's fog llc - hydrogen peroxide (unii: bbx060an9v) (hydrogen peroxide - unii:bbx060an9v) - antiseptic, hand sanitizer hand sanitizer to help reduce bacteria that potentially can cause disease. for use when soap and water are not available. - in children less than 2 months of age - on open skin wounds stop use and ask a doctor if irritation or rash occurs. these may be signs of a serious condition.

Bandaríkin - enska - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - cetirizine hcl, usp 5 mg pseudoephedrine hcl, usp 120 mg - antihistamine nasal decongestant - temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat nasal congestion - runny nose - sneezing - itchy, watery eyes - itching of the nose or throat - nasal congestion - reduces swelling of nasal passages - temporarily relieves sinus congestion and pressure - temporarily restores freer breathing through the nose - if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine. - if you are now taking a prescription monoamine oxidase inhibitor (maoi) (cer tain drugs for depression, psychiatric, or emotional conditions, or parkinson's disease), or for 2 weeks af ter stopping the maoi drug. if you do not know if your prescription drug contains an maoi, ask a doctor or pharmacist before taking this product. - heart disease - thyroid disease - diabetes - glaucoma - high blood pressure - trouble urinating due t

Bandaríkin - enska - NLM (National Library of Medicine)

lifestar pharma llc - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride injection, usp is indicated for the following: - rapid conversion to sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory bypass tracts (wolff-parkinson-white [w-p-w] and lown-ganong- levine [l-g-l] syndromes). when clinically advisable, appropriate vagal maneuvers (e.g., valsalva maneuver) should be attempted prior to verapamil hydrochloride administration. - temporary control of rapid ventricular rate in atrial flutter or atrial fibrillation except when the atrial flutter and/or atrial fibrillation are associated with accessory bypass tracts (wolff-parkinson-white (w-p-w) and lown-ganong-levine (l-g-l) syndromes). in controlled studies in the united states, about 60% of patients with supraventricular tachycardia converted to normal sinus rhythm within 10 minutes after intravenous verapamil hydrochloride. uncontrolled studies reported in the world literature describe a conversion rate of about 80%. about 70% of patients with atrial flutte

Bandaríkin - enska - NLM (National Library of Medicine)

sun pharmaceutical industries limited - ondansetron (unii: 4af302esos) (ondansetron - unii:4af302esos) - ondansetron 4 mg - - prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin ≥ 50 mg/m2 . - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. - prevention of nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen. - prevention of postoperative nausea and/or vomiting. as with other antiemetics, routine prophylaxis is not recommended for patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively. in patients where nausea and/or vomiting must be avoided postoperatively, ondansetron orally disintegrating tablets are recommended even where the incidence of postoperative nausea and/or vomiting is low. the concomitant use of apomorphine with ondansetron is contraindicated based on reports of profound hypotension and loss of consciousness when apomorp

Bandaríkin - enska - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine tablets  are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older. desloratadine tablets  are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older. desloratadine tablets  are indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 12 years of age and older. desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions (5.1) and adverse reactions (6.2)]. risk summary the limited available data with desloratadine in pregnant women are not sufficient to inform a drug- associated risk for major birth defects and miscarriage. there are no adequate and well-controlled studies in pregnant women. desloratadine given during organogenesis to pregnant rats

Bandaríkin - enska - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - fingolimod hydrochloride (unii: g926ec510t) (fingolimod - unii:3qn8byn5qf) - fingolimod capsules are indicated for the treatment of relapsing forms of multiple sclerosis (ms), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older. fingolimod is contraindicated in patients who have: - in the last 6 months experienced myocardial infarction, unstable angina, stroke, transient ischemic attack (tia), decompensated heart failure requiring hospitalization or class iii/iv heart failure - a history or presence of mobitz type ii second-degree or third-degree av block or sick sinus syndrome, unless patient has a functioning pacemaker [see warnings and precautions (5.1)] - a baseline qtc interval ≥ 500 msec - cardiac arrhythmias requiring anti-arrhythmic treatment with class ia or class iii anti-arrhythmic drugs - had a hypersensitivity reaction to fingolimod or any of the excipients in fingolimod capsules. observed reactions include rash, urticaria and angioedema upon treatment initiation [see warni